Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8640

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,640 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
003006 Chongqing Baiya Sanitary Products	CN¥25.75	2.1%	63.5%	CN¥11.1b	CN¥28.50	PE37.6x	E26.1%	2.1%	Household
SKS SKS Technologies Group	AU$1.95	-2.0%	634.0%	AU$218.0m	AU$2.15	PE32.9x	E24.8%	0.5%	Capital Goods
002827 Tibet GaoZheng Explosive	CN¥29.78	-3.2%	82.8%	CN¥8.2b	n/a	PE65.5x	E46.7%	0.5%	Materials
INIT Initiator Pharma	SEK 7.10	1.4%	-22.3%	SEK 399.3m	SEK 22.50	PB16.5x	E31.7%	n/a	Pharmaceuticals & Biotech
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م3.51	5.1%	100.3%	ج.م5.3b	ج.م5.02	PE19.8x	E30.7%	1.9%	Pharmaceuticals & Biotech
RHM Rheinmetall	€612.80	1.2%	115.0%	€26.6b	€721.93	PE38.8x	E29.9%	0.9%	Capital Goods
AGP Altea Green Power	€6.45	-2.0%	17.3%	€111.7m	€12.85	PE16.5x	E22.1%	n/a	Capital Goods
MBTN Meyer Burger Technology	CHF 2.19	-22.2%	-98.5%	CHF 67.7m	CHF 6.03	PS0.8x	E110.7%	n/a	Semiconductors
FWRY Fawry for Banking Technology and Electronic PaymentsE	ج.م8.66	-3.2%	46.5%	ج.م29.5b	ج.م11.67	PE23.8x	E27.4%	n/a	Diversified Financials
ACE Ascelia Pharma	SEK 3.18	0.6%	-16.6%	SEK 305.1m	SEK 8.25	PB2.8x	E47.2%	n/a	Pharmaceuticals & Biotech
MVW M Vest Water	NOK 9.00	5.3%	42.9%	NOK 294.5m	NOK 11.70	PS15.4x	E71.7%	n/a	Materials
CADLR Cadeler	NOK 63.60	-5.6%	44.2%	NOK 22.3b	NOK 82.90	PE208.1x	E70.4%	n/a	Capital Goods
ICOP I.CO.P.. Società Benefit	€8.30	4.8%	n/a	€229.4m	€9.80	PE45.4x	E49.2%	n/a	Capital Goods
WAYS Waystream Holding	SEK 15.98	-8.6%	-34.2%	SEK 129.0m	SEK 36.50	PS1x	E113.3%	0%	Tech
NVG Novavis Group	zł1.24	-17.3%	-41.5%	zł43.4m	zł3.04	PS8.9x	E62.2%	4.8%	Diversified Financials
ZVRA Zevra Therapeutics	US$8.48	-4.7%	73.1%	US$450.5m	US$20.00	PS18.5x	E73.5%	n/a	Pharmaceuticals & Biotech
ONON On Holding	US$56.64	2.6%	80.7%	US$18.5b	US$60.34	PE128.5x	E29.4%	n/a	Consumer Durables
NEWBRY Newbury Pharmaceuticals	SEK 3.50	-3.3%	-6.9%	SEK 84.9m	SEK 8.00	PS2.3x	E130.0%	n/a	Pharmaceuticals & Biotech
PHM Pharma Mar	€76.50	-3.0%	74.9%	€1.3b	€83.20	PE2157.1x	E56.2%	0.8%	Pharmaceuticals & Biotech
TVTX Travere Therapeutics	US$17.14	-8.6%	96.6%	US$1.5b	US$27.40	PS7.3x	E72.5%	n/a	Pharmaceuticals & Biotech
TGTX TG Therapeutics	US$33.57	6.0%	78.5%	US$4.9b	US$40.75	PS18.2x	E57.0%	n/a	Pharmaceuticals & Biotech
ARES Ares Management	US$178.33	1.3%	52.2%	US$57.5b	US$181.00	PE83.3x	E38.5%	2.1%	Diversified Financials
ALNY Alnylam Pharmaceuticals	US$246.58	-2.9%	31.5%	US$31.5b	US$299.11	PS15.2x	E70.3%	n/a	Pharmaceuticals & Biotech
MX1 Micro-X	AU$0.077	-13.5%	-30.0%	AU$40.7m	AU$0.19	PS2.9x	E68.7%	n/a	Healthcare

Page 1 of 360